MARISSA BROSMER: Open Payments
NPI 1497303572 · JASPER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$161 in 9 payments from 6 companies in 2025. Trend: 2023 $91 · 2024 $135 · 2025 $161
Food & beverage: $161
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| Novo Nordisk Inc | 2 | $41 |
| Boston Scientific Corporation | 1 | $24 |
| Lilly USA, LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: LEQVIO, Wegovy, WATCHMAN FLX, ZEPBOUND, FARXIGA, REPATHA.
Industry payments across IN — which companies pay providers there.
